diethylstilbestrol has been researched along with 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariazi, EA; Arterburn, JB; Black, MA; Brailoiu, E; Cunliffe, HE; Donato, AL; Dun, NJ; Jordan, VC; Oprea, TI; Prossnitz, ER; Shupp, HA; Slifker, MJ; Yerrum, S | 1 |
1 other study(ies) available for diethylstilbestrol and 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone
| Article | Year |
|---|---|
The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
Topics: Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclopentanes; Diethylstilbestrol; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Tumor Suppressor Protein p53 | 2010 |